The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma

home / scientific-interchange-and-workshop / the-evolving-treatment-landscape-in-relapsed-refractory-follicular-lymphoma
Krish Patel, MD

EP. 1: Dr. Patel on Factors to Consider When Treating Relapsed/Refractory Follicular Lymphoma

September 29th 2022

Krish Patel, MD, discusses the factors to consider when treating patients with relapsed and/or refractory follicular lymphoma.

Solly Chedid, MD

EP. 2: Dr. Chedid on Understanding Treatment Efficacy in Follicular Lymphoma

September 29th 2022

Solly Chedid, MD, discusses the elements of effective therapy in follicular lymphoma.

Madan L. Arora, MD

EP. 3: Dr. Arora on the Evolution of Treatment in Follicular Lymphoma

September 29th 2022

Madan L. Arora, MD, discusses the evolution of treatment in follicular lymphoma.

Solly Chedid, MD

EP. 4: The Evolving Treatment Landscape in Relapsed/ Refractory Follicular Lymphoma

November 4th 2022

On September 8, 2022, OncLive® brought together physicians who treat FL to participate in a virtual workshop and discuss the treatment landscape and management of patients with relapsed/refractory (R/R) FL. The discussion was led by Krish Patel, MD; perspectives and insights on current treatment options, trial data, and other novel therapies were exchanged.